Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119888276 | 11988827 | 6 | F | 201601 | 20160902 | 20160202 | 20160913 | EXP | US-PFIZER INC-2016049674 | PFIZER | 89.00 | YR | F | Y | 47.36000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119888276 | 11988827 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | 1 DF, 2X/DAY (0.125 MG) | 20931 | 1 | DF | CAPSULE, HARD | BID | |||||||
| 119888276 | 11988827 | 2 | I | TIKOSYN | DOFETILIDE | 1 | 1 DF, 2X/DAY (0.125 MG) (MORNING AND NIGHT) | 20931 | 1 | DF | CAPSULE, HARD | BID | |||||||
| 119888276 | 11988827 | 3 | I | ELIQUIS | APIXABAN | 1 | Unknown | 2.5 MG, 2X/DAY | 0 | 2.5 | MG | FILM-COATED TABLET | BID | ||||||
| 119888276 | 11988827 | 4 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | 2.5 MG, AS NEEDED | 0 | 2.5 | MG | |||||||||
| 119888276 | 11988827 | 5 | C | LASIX | FUROSEMIDE | 1 | Unknown | 40 MG, AS NEEDED | 0 | 40 | MG | ||||||||
| 119888276 | 11988827 | 6 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 10 MG, DAILY (1) | 0 | 10 | MG | TABLET | ||||||||
| 119888276 | 11988827 | 7 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK UNK, DAILY (10 MG 1/2 TAB DAILY) | 0 | TABLET | ||||||||||
| 119888276 | 11988827 | 8 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Unknown | 50 MG, DAILY (25 MG 2 DAILY) | 0 | 50 | MG | ||||||||
| 119888276 | 11988827 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 37.5 MG, DAILY | 0 | 37.5 | MG | TABLET | |||||||
| 119888276 | 11988827 | 10 | C | VIT. D | 2 | UNK, DAILY (2 DAILY ) | 0 | ||||||||||||
| 119888276 | 11988827 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 400 MG, UNK | 0 | 400 | MG | |||||||||
| 119888276 | 11988827 | 12 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 1 DF, PRN | 0 | 1 | DF | ||||||||
| 119888276 | 11988827 | 13 | C | VIT B | VITAMIN B | 1 | Unknown | UNK UNK, MONTHLY | 0 | INJECTION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119888276 | 11988827 | 1 | Atrial fibrillation |
| 119888276 | 11988827 | 2 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119888276 | 11988827 | HO |
| 119888276 | 11988827 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119888276 | 11988827 | Drug interaction | |
| 119888276 | 11988827 | Ear haemorrhage | |
| 119888276 | 11988827 | Epistaxis | |
| 119888276 | 11988827 | Eye haemorrhage | |
| 119888276 | 11988827 | Eye pruritus | |
| 119888276 | 11988827 | Fall | |
| 119888276 | 11988827 | Internal haemorrhage | |
| 119888276 | 11988827 | Myocardial infarction | |
| 119888276 | 11988827 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119888276 | 11988827 | 2 | 20151228 | 0 | ||
| 119888276 | 11988827 | 3 | 20150716 | 0 |